SCHEMBL28677140

SCHEMBL28677140

CSc1ncc2c(C)c(Br)c(=O)n([C@H]3CCN(C(=O)OC(C)(C)C)C3)c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.49
TNF P01375 2/20 0.40
LITAF Q99732 2/20 0.40
CDK4 P11802 8/20 0.38
CCND1 P24385 8/20 0.38
CCND2 P30279 7/20 0.38
CCND3 P30281 7/20 0.38
EGFR P00533 2/20 0.37
CCNA2 P20248 2/20 0.37
CDK2 P24941 2/20 0.37
CCNB2 O95067 1/20 0.37
CCNE2 O96020 1/20 0.37
CDK1 P06493 1/20 0.37
FGFR1 P11362 1/20 0.37
CCNB1 P14635 1/20 0.37
FGFR2 P21802 1/20 0.37
FGFR4 P22455 1/20 0.37
FGFR3 P22607 1/20 0.37
CCNE1 P24864 1/20 0.37
CCNA1 P78396 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22553544 0.95 PIK3CA (0.43) PIK3CATNFLITAFCDK4CCND1
SCHEMBL22566623 0.89 PIK3CA (0.49) PIK3CACDK4CCND1CCND2CCND3
SCHEMBL22553522 0.87 CDK4 (0.41) PIK3CACDK4CCND1CCND2CCND3
SCHEMBL22557914 0.87 CDK4 (0.41) PIK3CACDK4CCND1CCND2CCND3
SCHEMBL22566624 0.84 PIK3CA (0.46) PIK3CATNFLITAFCDK4CCND1
SCHEMBL22566636 0.84 CDK4 (0.53) PIK3CATNFLITAFCDK4CCND1
SCHEMBL22557912 0.83 CDK4 (0.44) PIK3CACDK4CCND1CCND2CCND3
SCHEMBL22566488 0.83 CDK4 (0.46) PIK3CACDK4CCND1CCND2CCND3
SCHEMBL22566485 0.79 PIK3CA (0.40) PIK3CATNFLITAFCDK4CCND1
SCHEMBL23633060 0.78 PIK3CA (0.41) PIK3CATNFLITAFCDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007697-A Antiproliferative agents for the treatment of PAH 辉瑞公司 2022-02-01 CN disclosed